Publications by authors named "Francisco Tejerina-Picado"

Background: Patients with hematological malignancies (HM) are at high risk of COVID-19 progression. Hence, early treatments to prevent progression are needed. The aim of our work was to evaluate the effectiveness and safety of remdesivir (RDV) and SARS-CoV-2 monoclonal antibodies (mAb) in patients with HM and mild-to-moderate disease in real clinical practice.

View Article and Find Full Text PDF
Article Synopsis
  • A retrospective study investigated the impact of SARS-CoV-2 on HIV patients, focusing on risk factors for respiratory failure (RF) among 177 participants aged over 18, diagnosed between March 2020 and April 2021.
  • The study revealed that most patients were on antiretroviral therapy (ART) with 91.3% having an undetectable viral load; however, 25% experienced RF, and 31% developed bilateral pneumonia.
  • Key risk factors for RF included older age and a CD4 count below 350 cells/μL, indicating that individuals with lower immune function are significantly more vulnerable to severe COVID-19 outcomes.
View Article and Find Full Text PDF

The incidence of classical Hodgkin lymphoma (cHL) in the HIV-1 setting has increased 5-25-fold compared to that observed in the general population. This study aimed to determine whether selected micro RNAs (miRs) and other soluble biomarkers and cellular subsets are dysregulated in cHL and could be used as biomarkers. This was a retrospective and longitudinal matched case-control study of 111 Caucasian, HIV-1-infected adult individuals, including 37 individuals with cHL and 74 with no type of cancer.

View Article and Find Full Text PDF

Lymphogranuloma venereum (LGV) is a sexually transmitted infection caused by invasive serovars of Chlamydia trachomatis. There have been only a few case reports of oropharyngeal C. trachomatis infection complicated with cervical LGV.

View Article and Find Full Text PDF